Immune checkpoint inhibitors (ICIs) are revolutionizing cancer care-but they can also ignite rare, potentially fatal immune-mediated toxicities. Among the most dangerous is myocarditis, a stealthy cardiac complication with high mortality if missed. In this fast-paced, high-yield session, Dr. Mohamed Hagahmed unpacks the clinical red flags of ICI-related myocarditis, explores its pathophysiology, and shares real-world strategies to improve early recognition in acute and emergency care settings. Attendees will learn how to distinguish myocarditis from more common presentations, identify subtle ECG and troponin clues, and understand when to escalate for advanced cardiac or oncologic consultation. Whether you work in the ED, ICU, or general medicine, this talk will equip you to detect the dangerous intersection of immunotherapy and cardiac injury-before it's too late.